Amphastar Pharmaceutical (amph 2 03/15/29)
13F holders, Q1 2026 (March 31)5holders −1
1new positions
1sold out
$0.90avg. 13F price*
At the end of Q1 2026, 5 institutions reported holding Amphastar Pharmaceutical (amph 2 03/15/29) in their 13F filings, down 1 from Q4 2025. 1 opened new positions and 1 sold out. The largest holders were Ssi Investment Management LLC ($323K), Bank of New York Mellon Corp ($272K) and Financial Sense Advisors, Inc. ($199K).
- Company
- Amphastar Pharmaceutical (amph 2 03/15/29)
- CUSIP
- 03209RAB9
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $323K |
| Exits | 1 | $128K |
All 13F filers, Q4 2025 → Q1 2026: 358,000 shares bought and 154,000 shares sold, net +204,000 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 5 holders
| Ssi Investment Management LLC | 0.03% | New | 358,000 | $323K |
| Bank of New York Mellon Corp | 0.00% | No change | 300,000 | $272K |
| Financial Sense Advisors, Inc. | 0.05% | Reduce -6.4% | 220,000 | $199K |
| Cetera Investment Advisers | 0.00% | No change | 111,000 | $100K |
| Choreo, LLC | 0.00% | No change | 37,000 | $33K |
"% of holder's portfolio" is AMPHASTAR PHARMACEUTICAL (AMPH 2 03/15/29)'s weight in each manager's 13F, not the share of Amphastar Pharmaceutical (amph 2 03/15/29) the manager owns.